These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 10239185)

  • 1. Hazards surround I.V. admixtures.
    Dinel B
    Hosp Adm Can; 1978 Sep; 20(9):21, 23. PubMed ID: 10239185
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASHP--hospital intravenous admixture program certification.
    Turco S
    Hosp Pharm; 1978 Jun; 13(6):306, 356. PubMed ID: 10307642
    [No Abstract]   [Full Text] [Related]  

  • 4. Panel discussion: hospital intravenous additive programs. I. An analysis of a hospital's I.V. additive service.
    Schwarz MA
    Bull Parenter Drug Assoc; 1969; 23(2):78-80. PubMed ID: 5776422
    [No Abstract]   [Full Text] [Related]  

  • 5. I.V. additives move to the pharmacy.
    Peritore SP; Rosenberg JM
    Hospitals; 1971 Dec; 45(24):84-91. PubMed ID: 5135288
    [No Abstract]   [Full Text] [Related]  

  • 6. Centralized intravenous admixture program for nine British hospitals.
    Tallett ER
    Am J Hosp Pharm; 1978 Feb; 35(2):163-5. PubMed ID: 626198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations to pharmacists for solving problems with large-volume parenterals.
    Am J Hosp Pharm; 1976 Mar; 33(3):231-6. PubMed ID: 816199
    [No Abstract]   [Full Text] [Related]  

  • 8. Outsourcing inpatient i.v. compounding: expense and medication error implications.
    Burruss RA; Carroll NV; Schraa C; Burton B
    Pharm Pract Manag Q; 1996 Oct; 16(3):52-9. PubMed ID: 10166235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premixed intravenous admixtures: a critical challenge for hospital pharmacy.
    Loeb AJ; Fishman DA; Kochis TR
    Am J Hosp Pharm; 1983 Jun; 40(6):1041-3. PubMed ID: 6869392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assurance in I.V. admixture programs.
    Turco SJ
    Hosp Pharm; 1979 Jun; 14(6):307, 311-3. PubMed ID: 10242204
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of an IV admixture program in a 167-bed hospital.
    Wyatt BK
    Hosp Pharm; 1975 Jun; 10(6):225-9. PubMed ID: 10237880
    [No Abstract]   [Full Text] [Related]  

  • 12. Centralized intravenous additive services (CIVAS): the state of the art in 2010.
    Hecq JD
    Ann Pharm Fr; 2011 Jan; 69(1):30-7. PubMed ID: 21296215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collecting i.v. workload data.
    Gary-Fritz K; Placko JS
    Am J Hosp Pharm; 1986 Aug; 43(8):1914. PubMed ID: 3752128
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premixed intravenous admixtures: a positive development for hospital pharmacy.
    Lee HE
    Am J Hosp Pharm; 1983 Jun; 40(6):1043-4. PubMed ID: 6869393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommended methods for compounding intravenous admixtures in hospitals.
    Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compounding times and contamination rates associated with the preparation of intravenous admixtures in three types of plastic containers.
    Allinson RR; Stach PE; Sherrin TP; Latiolais CJ
    Am J Hosp Pharm; 1979 Apr; 36(4):513-7. PubMed ID: 433938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: Solving problems associated with large-volume parenterals. I: pharmacist responsibility for compounding intravenous admixtures.
    Zellmer WA
    Am J Hosp Pharm; 1975 Mar; 32(3):255. PubMed ID: 1136972
    [No Abstract]   [Full Text] [Related]  

  • 19. Centralized accountability for drug-related activities in the small hospital.
    Garrison TJ
    Hosp Formul; 1975 Sep; 10(9):430-7. PubMed ID: 10237849
    [No Abstract]   [Full Text] [Related]  

  • 20. [I.V. preparations in practice: a study].
    Schaaf D
    Infusionsther Klin Ernahr; 1980 Dec; 7(6):320-2. PubMed ID: 7275283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.